Banque de Luxembourg Investments (BLI)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Banque de Luxembourg Investments (BLI)'s VRTX Position: Q1 2026 in Review
Banque de Luxembourg Investments (BLI) held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 5,500 shares worth $2.46M. The position accounts for 0.07% of the portfolio, ranked #148.
Banque de Luxembourg Investments (BLI) first reported a position in VRTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.87M in Q2 2025. 1,691 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Banque de Luxembourg Investments (BLI) held 5,500 shares of Vertex Pharmaceuticals worth $2.46M as of Q1 2026.
- Banque de Luxembourg Investments (BLI) left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
- Vertex Pharmaceuticals made up 0.07% of Banque de Luxembourg Investments (BLI)'s portfolio in Q1 2026, its #148 holding.
- Banque de Luxembourg Investments (BLI) first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
- Banque de Luxembourg Investments (BLI)'s Vertex Pharmaceuticals position peaked at $2.87M in Q2 2025.
- 1,691 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.